ALLMedicine™ Hypoglycemia Center
Research & Reviews 7,894 results
https://doi.org/10.1111/dom.15051
Diabetes, Obesity & Metabolism; Pasqualotto E, Maintinguer RDS et. al.
Mar 18th, 2023 - To assess the efficacy of bexagliflozin in reducing glycated hemoglobin (HbA1c) and the occurrence of side effects in patients with type 2 diabetes (DM2). We searched PubMed, Embase, Cochrane and ClinicalTrials.gov databases for placebo-controlled...
https://doi.org/10.1371/journal.pone.0283148
PloS One; Søholm U, Broadley M et. al.
Mar 18th, 2023 - The aim of this study was to determine the acceptability and psychometric properties of the Hypo-METRICS (Hypoglycemia MEasurement, ThResholds and ImpaCtS) application (app): a novel tool designed to assess the direct impact of symptomatic and asy...
https://doi.org/10.1016/j.pcd.2023.03.002
Primary Care Diabetes; Zeitoun MH, Abdel Reheem AA et. al.
Mar 17th, 2023 - Emotional problems including anxiety, depression and fear of hypoglycemia (FOH) are common in patients with type 1 diabetes mellitus (T1DM). The aim of this study was to determine the prevalence of depressive and anxiety symptoms among patients wi...
https://doi.org/10.1016/j.ienj.2023.101270
International Emergency Nursing; Yücel H, Eksi A et. al.
Mar 17th, 2023 - It is aimed to evaluate the knowledge of Pre-Hospital Emergency Health Services (PHEMS) staff about the treat and release criteria in hypoglycemia cases and their attitudes in the decision-making processes related to hospitalization. The sample of...
https://doi.org/10.2337/dc22-2395
Diabetes Care; Kazda CM, Bue-Valleskey JM et. al.
Mar 16th, 2023 - Basal Insulin Fc (BIF; insulin efsitora alfa; LY3209590), a fusion protein combining a novel single-chain insulin variant with a human IgG Fc domain, is designed for once-weekly basal insulin administration. This phase 2 study assessed safety and ...
Guidelines 19 results
https://doi.org/10.1016/j.jogc.2022.12.006
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Liauw J, Foggin H et. al.
Dec 27th, 2022 - To update recommendations for administration of antenatal corticosteroids in the late preterm period. Pregnant individuals at risk of preterm birth from 34 to 366 weeks gestation. Administration or non-administration of a single course of antenata...
https://doi.org/10.1210/clinem/dgac596
The Journal of Clinical Endocrinology and Metabolism; McCall AL, Lieb DC et. al.
Dec 9th, 2022 - Hypoglycemia in people with diabetes is common, especially in those taking medications such as insulin and sulfonylureas (SU) that place them at higher risk. Hypoglycemia is associated with distress in those with diabetes and their families, medic...
https://doi.org/10.1016/j.eprac.2022.08.002
Endocrine Practice : Official Journal of the American Col... Blonde L, Umpierrez GE et. al.
Aug 14th, 2022 - The objective of this clinical practice guideline is to provide updated and new evidence-based recommendations for the comprehensive care of persons with diabetes mellitus to clinicians, diabetes-care teams, other health care professionals and sta...
https://doi.org/10.1001/jama.2021.11922
JAMA , Davidson KW et. al.
Aug 11th, 2021 - Gestational diabetes is diabetes that develops during pregnancy. Prevalence of gestational diabetes in the US has been estimated at 5.8% to 9.2%, based on traditional diagnostic criteria, although it may be higher if more inclusive criteria are us...
https://doi.org/10.1016/j.ajog.2021.07.023
American Journal of Obstetrics and Gynecology; , Reddy UM et. al.
Aug 8th, 2021 - The administration of antenatal corticosteroids has been widely adopted as the standard of care in the management of pregnancies at risk for preterm delivery before 37 weeks of gestation, with the primary goal of reducing neonatal morbidity. Howev...
Drugs 329 results see all →
Clinicaltrials.gov 1,263 results
https://clinicaltrials.gov/ct2/show/NCT05762783
Mar 10th, 2023 - Background: Adolescents with type 1 diabetes (T1D) experience more disturbed sleep compared to their healthy peers, and there is some evidence that they spend less time in deep sleep, which is the most restoring part of sleep. Disturbed sleep may ...
https://clinicaltrials.gov/ct2/show/NCT05569876
Mar 10th, 2023 - While hypoglycemia has been widely studied in medical research, studies assessing vocal changes associated with this state are limited. This study aims at collecting a data set labelled with the gold standard (blood glucose) to provide a solid bas...
https://clinicaltrials.gov/ct2/show/NCT00001276
Mar 10th, 2023 - The purpose of this study is to gain knowledge and experience in the diagnosis and therapy of patients with fasting hypoglycemia due to diverse etiologies, such as insulinomas. Study subjects will be evaluated and treated for their particular cond...
https://clinicaltrials.gov/ct2/show/NCT04430660
Mar 9th, 2023 - A recent pilot study, GLIMPSE (NCT02690168), was recently completed which demonstrated that the rate of glial acetate metabolism (GAM) is closely associated with susceptibility to fasting-induced hypoglycemia in healthy adults. Insulin-induced hyp...
https://clinicaltrials.gov/ct2/show/NCT05762107
Mar 9th, 2023 - The goal of this clinical trial is to learn about the effect of the study drug (ZT-01) on low blood sugar (hypoglycemia) in adults with type 1 diabetes (T1D) who have been having low blood sugars ("hypos") at night. ZT-01 increases the amount of a...
News 1,786 results
https://www.medpagetoday.com/endocrinology/type1diabetes/103548
Mar 15th, 2023 - Very young children with type 1 diabetes saw glycemic benefits when using a hybrid closed-loop system, the randomized PEDAP trial showed. Among 102 children ages 2 to 5 years, the mean percentage of time that the glucose level was within the targe...
https://www.medpagetoday.com/endocrinology/type1diabetes/103258
Feb 24th, 2023 - A calcium channel blocker helped to partially preserve stimulated C-peptide secretion in kids with newly diagnosed type 1 diabetes, although more intensive management did not, according to a randomized clinical trial. Children and adolescents who ...
https://www.medpagetoday.com/neurology/dementia/103123
Feb 15th, 2023 - An older diabetes drug may help lower the risk for dementia in older people with new-onset type 2 diabetes, a Korean study suggested. Among more than 91,000 newly-diagnosed diabetes patients ages 50 and older without a history of dementia, pioglit...
https://www.mdedge.com/type-2-diabetes-icymi/article/261142/diabetes/review-glycemia-reduction-approaches-diabetes-grade
Andrew Ahmann, MD, MS
Feb 15th, 2023 - Type 2 diabetes (T2D) is a chronic, progressive disease marked by ongoing decline in insulin sensitivity and beta-cell function over time. Clinical trials have shown that lowering A1C to ∼7.
https://www.medpagetoday.com/endocrinology/generalendocrinology/102897
Jan 31st, 2023 - The 24-month ALERTT1 trial found that switching to a real-time continuous glucose monitor from an intermittently scanned one significantly improved glycemic control and hypoglycemia worry score for people with type 1 diabetes. (The Lancet Diabetes...